Nucleoporins in cardiovascular disease.

Area of Science:

• Molecular Biology
• Cardiovascular Science
• Cell Biology

Background:

• Cardiovascular disease (CVD) presents significant global health and economic challenges.
• Understanding the molecular underpinnings of polygenic cardiac conditions is crucial for developing new treatments.
• Nuclear envelope proteins, specifically nucleoporins, have emerged as potential regulators in cellular processes.

Purpose of the Study:

• To review and synthesize current literature on nucleoporins and their connection to cardiac pathologies.
• To explore the potential role of nucleoporins as facilitators in the development and progression of heart disease.

Main Methods:

• Literature review and synthesis of existing research on nucleoporins and cardiovascular disorders.
• Analysis of reported associations between nucleoporin deregulation and various cardiomyopathies and heart conditions.

Main Results:

• Nucleoporin deregulation is consistently reported in conditions such as ischemic and dilated cardiomyopathies, arrhythmias, and valvular disorders.
• Evidence suggests nucleoporin impairment is a significant, yet understudied, factor in cardiopathology.

Conclusions:

• Nucleoporins are implicated in a range of cardiac pathologies.
• Further research into nucleoporins may uncover novel mechanisms and therapeutic targets for cardiovascular disease.